HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lindsay R Riddle Selected Research

N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 3- yl)benzamide

2/2011Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lindsay R Riddle Research Topics

Disease

2Dyskinesias (Dyskinesia)
02/2011 - 05/2009
2Parkinson Disease (Parkinson's Disease)
02/2011 - 05/2009

Drug/Important Bio-Agent (IBA)

2Levodopa (L Dopa)FDA LinkGeneric
02/2011 - 05/2009
2Dopamine Receptors (Dopamine Receptor)IBA
02/2011 - 05/2009
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2011
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA
02/2011
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 3- yl)benzamideIBA
02/2011
1Dopamine Agonists (Dopamine Agonist)IBA
05/2009
1phenylpiperazineIBA
05/2009
1SK&F 81297IBA
05/2009
1Bromocriptine (Parlodel)FDA LinkGeneric
05/2009
1Oxidopamine (6 Hydroxydopamine)IBA
05/2009